Loading…
Ypsomed's YpsoMate autoinjector achieved its first commercial market entry, with Terumo Corporation filling its PLAJEX syringe with the drug Hulio (adalimumab) and assembling it with the YpsoMate. First commercial deliveries from Switzerland to Japan are completed.